GlassScriptPhysician profile
Allison J Gilroy
NPI 1548807019
$2,035.04
in general payments reported to CMS, 2019-2025
22 companies · $771 in 2025
The $771 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $177 · 2024: $1,088 · 2025: $771.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,035.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $593.74 | 2023-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $251.02 | 2023-2025 | |
| Abbvie INC. | $227.21 | 2023-2025 | |
| Glaxosmithkline, LLC. | $209.34 | 2024-2025 | Arexvy, Trelegy Ellipta |
| Novo Nordisk INC | $196.73 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Boston Scientific Corporation | $91.34 | 2024-2025 | Watchman Access System |
| Eisai INC. | $70.14 | 2024-2025 | |
| Amgen INC. | $52.89 | 2024-2025 | Repatha, Otezla, Otezla |
| Astellas Pharma US INC | $45.06 | 2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $36.44 | 2023-2024 | |
| Exact Sciences Corporation | $28.56 | 2024-2025 | Cologuard Collection Kit |
| Inspire Medical Systems, INC. | $27.97 | 2025 | Inspire |
| Inogen, INC. | $24.76 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| E.R. Squibb & Sons, L.L.C. | $24.21 | 2024 | Eliquis |
| Axsome Therapeutics, INC. | $23.26 | 2025 | Auvelity |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $21.93 | 2025 | Freestyle Libre 3 |
| Corium, LLC | $20.99 | 2025 | Azstarys |
| Astrazeneca Pharmaceuticals LP | $20.14 | 2024 | Farxiga |
| Sanofi-Aventis U.S. LLC | $18.92 | 2023 | |
| Lundbeck LLC | $18.36 | 2024 | Rexulti |
| Alnylam Pharmaceuticals INC. | $18.32 | 2024 | Onpattro |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.71 | 2024 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Gilroy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.